Mass spectrometry has been applied successfully to the study of non-enzymat
ic protein glycation, which is a topic of wide interest in the diabetes fie
ld Low- and high-resolution mass spectra, GC/MS, and collisional activation
spectroscopy allow the structural identification and quantitative evaluati
on of advanced glycation end-products, which represent important molecules
for monitoring diabetes. More recently available techniques, such as ESI an
d MALDI/MS, have had a significant impact on analytical problems in diabete
s. In particular MALDI has been applied to the study of protein glycation i
n in vitro and in vivo conditions, because the number of glucose molecules
that condense onto the protein can be easily determined by this approach. I
n the former case, glycation kinetics have been studied in various sugars a
nd sugar concentrations, proteins, and buffer concentrations; in the latter
comparisons of MALDI spectra of circulating proteins from healthy and diab
etic subjects determine the exposure of patients to high glucose levels. Th
e method has been applied to an evaluation of the glycation level of immuno
globulins, and indicates that glycation takes place preferentially on the F
ab fragment of the protein, data are relevant in relating immunological imp
airment with glycation-induced changes in the functionality of immunoglobul
ins. (C) 2000 John Wiley & Sons, Inc.